A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)
Clinical trial NCT01604343 · COMPLETED
Trial details
- NCT number
- NCT01604343
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-15
- Primary completion
- 2015-09-02
- Enrollment
- 1670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.